This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Curiel, T. J. Articles by Zou, W. Search for Related Content PubMed PubMed Citation Articles by Curiel, T. J. Articles by Zou, W.

Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer

¹ Tulane University Health Science Center, New Orleans, Louisiana, and ² Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium

Angiogenesis is essential for both primary and metastatic tumor growth. Tumor blood vessel formation is complex and regulated by many factors. Ovarian carcinomas have a poor prognosis, often associated with multifocal intraperitoneal dissemination accompanied by intense neovascularization. To examine tumor angiogenesis in the tumor microenvironment, we studied malignant ascites of patients with untreated ovarian carcinoma. We observed high numbers of plasmacytoid dendritic cells (PDCs) and significant stromal-derived factor (CXCL-12/SDF)-1 in their malignant ascites, attracting PDCs into the tumor environment. We now show that tumor-associated PDCs induced angiogenesis in vivo through production of tumor necrosis factor and interleukin 8. By contrast, myeloid dendritic cells (MDCs) were absent from malignant ascites. MDCs derived in vitro suppressed angiogenesis in vivo through production of interleukin 12. Thus, the tumor may attract PDCs to augment angiogenesis while excluding MDCs to prevent angiogenesis inhibition, demonstrating a novel mechanism for modulating tumor neovascularization. Because dendritic cells (DCs) have long been known to affect tumor immunity, our data also implicate DCs in regulation of tumor neoangiogenesis, suggesting a novel role of DCs in tumor pathology.

This article has been cited by other articles:

				C-H. Hung, Y-T. Chu, J-L. Suen, M-S. Lee, H-W. Chang, Y-C. Lo, and Y-J. Jong Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues Eur. Respir. J., February 1, 2009; 33(2): 405 - 410. [Abstract] [Full Text] [PDF]

				M. Gelati, A. C. Aplin, E. Fogel, K. D. Smith, and R. F. Nicosia The Angiogenic Response of the Aorta to Injury and Inflammatory Cytokines Requires Macrophages J. Immunol., October 15, 2008; 181(8): 5711 - 5719. [Abstract] [Full Text] [PDF]

				A. N. Clark, R. Youkey, X. Liu, L. Jia, R. Blatt, Y.-J. Day, G. W. Sullivan, J. Linden, and A. L. Tucker A1 Adenosine Receptor Activation Promotes Angiogenesis and Release of VEGF From Monocytes Circ. Res., November 26, 2007; 101(11): 1130 - 1138. [Abstract] [Full Text] [PDF]

				F. Tian, S. Grimaldo, M. Fugita, J. Cutts, N. L. Vujanovic, and L.-Y. Li The Endothelial Cell-Produced Antiangiogenic Cytokine Vascular Endothelial Growth Inhibitor Induces Dendritic Cell Maturation J. Immunol., September 15, 2007; 179(6): 3742 - 3751. [Abstract] [Full Text] [PDF]

				I. Perrot, D. Blanchard, N. Freymond, S. Isaac, B. Guibert, Y. Pacheco, and S. Lebecque Dendritic Cells Infiltrating Human Non-Small Cell Lung Cancer Are Blocked at Immature Stage J. Immunol., March 1, 2007; 178(5): 2763 - 2769. [Abstract] [Full Text] [PDF]

				I. Kryczek, S. Wei, E. Keller, R. Liu, and W. Zou Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis Am J Physiol Cell Physiol, March 1, 2007; 292(3): C987 - C995. [Abstract] [Full Text] [PDF]

				B. Webster, E. H. Ekland, L. M. Agle, S. Chyou, R. Ruggieri, and T. T. Lu Regulation of lymph node vascular growth by dendritic cells J. Exp. Med., August 7, 2006; 203(8): 1903 - 1913. [Abstract] [Full Text] [PDF]

				S. Wei, I. Kryczek, L. Zou, B. Daniel, P. Cheng, P. Mottram, T. Curiel, A. Lange, and W. Zou Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma Cancer Res., June 15, 2005; 65(12): 5020 - 5026. [Abstract] [Full Text] [PDF]

				I. Kryczek, A. Lange, P. Mottram, X. Alvarez, P. Cheng, M. Hogan, L. Moons, S. Wei, L. Zou, V. Machelon, et al. CXCL12 and Vascular Endothelial Growth Factor Synergistically Induce Neoangiogenesis in Human Ovarian Cancers Cancer Res., January 15, 2005; 65(2): 465 - 472. [Abstract] [Full Text] [PDF]